En este estudio no aleatorizado no mostró impacto sobre el LDLc pero si sobre otros parámetros muy importantes... ➡️Mejora HOMA ➡️Mejora trigliceridos ➡️Mejora col remante J Atheroscler Thromb, 2019; 26: 000-000. https://t.co/xg0jwE8I3E https://t.co/6aa
RT @DiscoStew66: The cardiovascular benefit of SGLT2 inhibitors in diabetic patients with CAD may be due to their ability to reduce triglyc…
RT @DiscoStew66: The cardiovascular benefit of SGLT2 inhibitors in diabetic patients with CAD may be due to their ability to reduce triglyc…
The cardiovascular benefit of SGLT2 inhibitors in diabetic patients with CAD may be due to their ability to reduce triglycerides. I know another way to reduce triglycerides... https://t.co/UvO89yWhM9